![Tord Labuda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tord Labuda
Chief Executive Officer at
ALZINOVA AB
Profile
Tord Labuda is Chief Executive Officer at Alzinova AB since 2024.
Formerly, Dr. Labuda was Independent Director at NanoEcho AB from 2023 to 2026 and Vice President & Global Head-Clinical Development at LEO Pharma A from 2008 to 2023.
Education includes a doctorate from the University of Lund.
Tord Labuda active positions
| Companies | Position | Start |
|---|---|---|
| ALZINOVA AB | Chief Executive Officer | 2024-09-30 |
Former positions of Tord Labuda
| Companies | Position | End |
|---|---|---|
| NANOECHO AB | Director/Board Member | 2026-05-27 |
LEO Pharma A/S
 LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Corporate Officer/Principal | 2022-12-31 |
Education of Tord Labuda
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
57
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alzinova AB
 Alzinova AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides treatment for Alzheimer’s disease | Health Technology |
Nanoecho AB
 Nanoecho AB Medical SpecialtiesHealth Technology Develops medical ultrasound imaging equipment to treat rectal cancer | Health Technology |
- Stock Market
- Insiders
- Tord Labuda
